Medical network - April 28 April 14, people club department issued notice, 44 varieties should be brought into the 2017 national health insurance directory negotiations, cool slightly before the new medical insurance directory again triggered heated debate. 

 

It will benefit from the inclusion of roche's tumor drug 

 

Market data, based on PDB samples of domestic hospital in ATC classification for reference, the 44 varieties more negotiations on antitumor drugs and immune modulators, have clinical requirements have not been satisfied and the characteristics of high prices, and tumor biological drugs giant, roche, a total of 4 varieties for resistance (including three single + 1 for class). In 2016, roche will be it for non-small cell lung cancer treatment drug, 30% reduction (tarceva), not to enter the first national varieties list price negotiations, the final reduction of the 4 varieties is not known. 

 

 

Figure 1: the distribution of the treatment of national health insurance negotiations in 2017. 

 

On the other hand, from the point of dosage form distribution, in addition to the traditional preparations, the varieties of negotiations involving sustained-release dosage form, control quetiapine fumarate zyban, paroxetine hydrochloride enteric zyban, injecting paclitaxel liposome, and the corresponding related often release quick release varieties have been selected by national medicine, class a national health insurance directory, and the three are exclusive varieties, price negotiations will further strengthen the market competitiveness of the products. 

 

 

FIG. 2: the distribution of national health insurance negotiations in 2017. 

 

There are more health insurance coverage in traditional Chinese medicine, and the list of health insurance in the north is open 

 

Based on the PDB drug catalog database, 14 of the 44 negotiating categories have been included in local health care. The blood will be liquid, with as many as 22 regions, 70.96% of the region. In general, the area of traditional Chinese medicine class, noting that the generally high number of roche four varieties, there are three have entered the local health care, is expected in the future if not into the national health insurance, is expected to further expand in the region. 

 

 

FIG. 3: the distribution of health care in the region in 2017. 

 

, on the other hand, from the Angle of region, the distribution of 14 varieties more concentrated in gansu, ningxia, xinjiang, Tibet, qinghai and other regions, appear even 0 distribution in Beijing and Shanghai, zhejiang region has only one species, while the regional economy more developed, the market demand is big, even if you don't enter the health care also has a certain market, but if can add a fire through price negotiation, the market is expected to moderate. 

 

 

Figure 4. The distribution of health care in the region in 2017.